Clinical Trials in Arizona

Showing 7321-7340 of 16,770 trials

Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction

NCT03055832

The purpose of this study was to compare changes in meibomian gland dysfunction (MGD), tear break-up time (TBT) and evaporative dry eye (EDE) symptoms after treatment with either the iLux® 2020 System or the LipiFlow® Thermal Pulsation System.

Meibomian Gland Dysfunction

Tear Film Innovations, Inc.142 participantsStarted Feb 2017

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • San Diego, California, United States +4 more locations

COMPLETEDPhase 1/231 miles

Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

NCT01794520

The Phase 1 primary objectives of this study were to assess the safety profile, characterize pharmacokinetics (PK) and determine the dosing schedule, maximum tolerated dose (MTD), and recommended Phase 2 dose (RPTD) of ABT-199 (venetoclax) when administered in participants with relapsed or refractory multiple myeloma. This study also assessed the safety profile and PK of venetoclax in combination with dexamethasone in participants with t(11;14)-positive multiple myeloma. The Phase 2 primary objective was to further evaluate the objective response rate (ORR) and very good partial response or better rate (VGPR+) in participants with t(11;14)-positive multiple myeloma.

Relapsed/Refractory Multiple Myeloma

AbbVie117 participantsStarted Oct 2012

Scottsdale, Arizona, United States • Little Rock, Arkansas, United States • New Haven, Connecticut, United States +26 more locations

Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction

Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

Find Trials by Condition in Arizona

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4)

Intraoperative Brachytherapy for Central Nervous System Lesions: A Validation Study of a Radioactive Seed Loading Device

ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi

A Study of Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Participants

Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)

A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers

A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

Acquired Methemoglobinemia Observational Registry

Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

N99-02: Melphalan and Buthionine Sulfoximine

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

Evaluation of Safety and Efficacy of the BTL-785F Device for Non-invasive Facial Remodeling

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

Biomarker Cost-Benefit Analysis of EFNEP

Point-of-Care Immunoassay for Detection of Bacterial Sinusitis

Improving Cognition Via Exercise in Schizophrenia

Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002)